Asthma News and Research

RSS

Asthma is a common inflammatory disease affecting the airways that leads to shortness of breath, coughing and wheezing. Symptoms range from mild to severe but are generally manageable with appropriate treatment.

COVID-19 can cause sudden permanent hearing loss in rare cases

Many complications have been reported, including heart disease and prolonged respiratory issues in a group of people called “long-haulers.” Now, a new worrying finding shows that COVID-19 can cause sudden and irreversible hearing loss in patients.

15 Oct 2020

Certain live-attenuated vaccines can prevent severe complications of COVID-19

COVID-19 continues to wreak havoc globally, with over one million deaths to date. Yet what if an existing vaccine could make COVID-19 less deadly? A study just published put the theory to test, with promising results.

15 Oct 2020

Proactive interventions associated with reduced healthcare utilization, costs for children with asthma

A new study looking at data from tens of thousands of children with asthma finds that several widely available interventions are associated with both reduced medical costs and a reduced likelihood that the children will need to visit an emergency room or stay in the hospital.

13 Oct 2020

Analysis of existing comorbidities and COVID-19 mortality

As the COVID-19 pandemic continues to spread, and research related to potential risk factors for COVID-19 mortality continues, it is becoming clear that individuals with underlying comorbidities have a greater risk of death from COVID-19. The exact contribution of different comorbidities is unclear, however. Now, a new study published in the journal PLOS ONE dissects this topic and may help to quantify the risk posed by specific conditions and offer help with the prognosis.

11 Oct 2020

Exuberant activation of immune cells in severe COVID-19 resembles lupus

In severe cases of COVID-19, Emory researchers have been observing an exuberant activation of immune cells, resembling acute flares of systemic lupus erythematosus (SLE), an autoimmune disease.

9 Oct 2020

Impaired air quality associated with children's absences from school

In Salt Lake City schools, absences rise when the air quality worsens, and it's not just in times of high pollution or "red" air quality days--even days following lower levels of pollutions saw increased absences.

9 Oct 2020

Certain pre-existing conditions may highly increase a patient's risk of dying from COVID-19

A large, international study of COVID-19 patients confirmed that cardiovascular disease, hypertension, diabetes, congestive heart failure, chronic kidney disease, stroke and cancer can increase a patient's risk of dying from the virus.

8 Oct 2020

Young doctor succumbs to COVID, one of the south’s many health workers lost

It took Carrie Wanamaker several days to connect the face she saw on GoFundMe with the young woman she had met a few years before.

8 Oct 2020

Pre-existing conditions can increase patient's risk of dying from COVID-19

8 Oct 2020

Study provides greater detail about the characteristics of COVID-19 patients

Patients hospitalized with COVID-19 were more likely male, younger, and, in both the US and Spain, had fewer comorbidities and lower medication use than hospitalized influenza patients according to a recent study published by the Observational Health Data Sciences and Informatics community.

6 Oct 2020

Study reveals how ILCs develop, adapt, specialize in specific tissue environments

Specialized immune cells settle permanently in various tissues of the body and build "local task forces". Scientists from Würzburg have now discovered, how these cell populations can renew locally and can adapt to their specific environment.

1 Oct 2020

NIH awards $5 million grant to reduce COVID-19-related health disparities

To help reduce COVID-19-related health disparities in vulnerable populations in Texas, a multi-institutional team of researchers led by The University of Texas Health Science Center at Houston will identify disease hotspots and testing deserts in three racially diverse areas, and then develop and evaluate intervention strategies to increase COVID-19 testing.

30 Sep 2020

Sleep apnea increases risk of severe COVID 19

Coronavirus disease (COVID-19) is a respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. A subset of COVID-19 patients face a severe form of the disease with hospitalization, respiratory failure, or death. Severe COVID-19 is primarily characterized by respiratory distress, and the common risk factors are older age, obesity, cardiovascular disease, diabetes, and poor lung function.

29 Sep 2020

Cincinnati Children's research leads to approval of new drug for hypereosinophilic syndrome

Following two decades of research on a group of rare diseases called hypereosinophilic syndrome at Cincinnati Children's Hospital Medical Center, the U.S. Food and Drug Administration has approved the drug Nucala (mepolizumab) for use in the treatment of patients with hypereosinophilic syndrome.

28 Sep 2020

Health on wheels: Tricked-out RVs deliver addiction treatment to rural communities

Tonja Jimenez is far from the only person driving an RV down Colorado's rural highways. But unlike the other rigs, her 34-foot-long motor home is equipped as an addiction treatment clinic on wheels, bringing lifesaving treatment to the northeastern corner of the state, where patients with substance use disorders are often left to fend for themselves.

28 Sep 2020

Inhaled corticosteroids may not increase COVID-19 mortality

Inhaled corticosteroids (ICS) are the first line of treatment to counter the inflammatory pathology in several conditions, including asthma and chronic obstructive pulmonary disease (COPD). Now, a new study published in the journal The Lancet Respiratory Medicine in September 2020 reports on the actual role of ICS in reducing COVID-19 mortality.

28 Sep 2020

Study reveals the differences in non-COVID-19 hospital admissions during rebound period

While declines in U.S. hospital admissions during the onset of COVID-19 has been well-documented, little is known about how admissions during the rebound varied by age, insurance coverage and socioeconomic groups.

26 Sep 2020

SARS-CoV-2 emergence linked with decrease in circulation of common respiratory viruses

Analysis of samples taken to test for respiratory viruses over the past five years suggests that the emergence of SARS-CoV-2 was associated with a large drop in circulation of other common respiratory viruses during the first wave.

26 Sep 2020

FDA approves first drug for patients with hypereosinophilic syndrome in nearly 14 years

Today, the U.S. Food and Drug Administration approved Nucala (mepolizumab) for adults and children aged 12 years and older with hypereosinophilic syndrome (HES) for six months or longer without another identifiable non-blood related cause of the disease.

25 Sep 2020

Social inequities in Black and South Asian immigrants increase risk of severe COVID-19 infection

Black, South Asian and Aboriginal populations from disadvantaged socioeconomic backgrounds in Canada are nearly four times more likely to have three or more medical conditions that have been identified as risk factors for severe illness from COVID-19.

25 Sep 2020

Asthma News and Research

Further Reading

COVID-19 can cause sudden permanent hearing loss in rare cases

Certain live-attenuated vaccines can prevent severe complications of COVID-19

Proactive interventions associated with reduced healthcare utilization, costs for children with asthma

Analysis of existing comorbidities and COVID-19 mortality

Exuberant activation of immune cells in severe COVID-19 resembles lupus

Impaired air quality associated with children's absences from school

Certain pre-existing conditions may highly increase a patient's risk of dying from COVID-19

Young doctor succumbs to COVID, one of the south’s many health workers lost

Pre-existing conditions can increase patient's risk of dying from COVID-19

Study provides greater detail about the characteristics of COVID-19 patients

Study reveals how ILCs develop, adapt, specialize in specific tissue environments

NIH awards $5 million grant to reduce COVID-19-related health disparities

Sleep apnea increases risk of severe COVID 19

Cincinnati Children's research leads to approval of new drug for hypereosinophilic syndrome

Health on wheels: Tricked-out RVs deliver addiction treatment to rural communities

Inhaled corticosteroids may not increase COVID-19 mortality

Study reveals the differences in non-COVID-19 hospital admissions during rebound period

SARS-CoV-2 emergence linked with decrease in circulation of common respiratory viruses

FDA approves first drug for patients with hypereosinophilic syndrome in nearly 14 years

Social inequities in Black and South Asian immigrants increase risk of severe COVID-19 infection

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News